MFN pegs US net prices to the second-lowest net price in an eight-country basket, using rebate-inclusive definitions to limit list-price inflation and rebate-based circumvention. Prospective MFN for ...

Katie Eyes, MSW, reflects on 25 years of the BCBSNC Foundation and, over her 18 years with the organization, its shift toward ...

Swedish registry follow-up of >5.3 million pre-pandemic and >5.5 million pandemic adults linked death of a partner, child, ...

Tapia, MD, PhD, discusses the results of the ADAPT OCULUS trial, which found promising results for treating patients with ...

Rising rates appear concentrated in hormone receptor–positive disease, aligning with later age at first birth, fewer ...

FDA regulatory momentum includes priority review and breakthrough therapy designation for a potential first-in-class CHB ...

Healthcare data’s high fraud utility and broad clinical dependencies make ransomware uniquely harmful, coupling identity ...

Vepdegestrant becomes the first FDA-approved heterobifunctional protein degrader (PROTAC) in breast cancer, targeting ER ...

Shara Bialo, MD, emphasizes the crucial role of school nurses in early detection of type 1 diabetes. In recognition of ...

The US national crisis hotline, 988, was contacted over 18 million times since its launch in July of 2022; however, despite ...

Hospital-at-home (HaH) care was associated with lower in-hospital mortality and reduced emergency department use within 30 ...

Evidence suggests that adoption of oncology biosimilars in Medicare value-based payment models has produced substantial cost ...